Retatrutide Peptide (GLP-3) | 50mg
Buy Retatrutide Peptide (GLP-3) | 50mg
Product Overview & Analytical Specifications
Our laboratory team supplies this high-grade Retatrutide peptide (internationally designated as LY3437943) as a stable, freeze-dried lyophilized powder. Known widely in advanced metabolic literature and life-science forums as a “GLP-3” peptide, this compound represents the latest breakthrough in multi-receptor incretin mimetics.
We synthesize every batch using high-fidelity, automated Solid-Phase Peptide Synthesis (SPPS). Next, we purify the compound via multi-stage preparative High-Performance Liquid Chromatography (HPLC). Consequently, this exhaustive manufacturing process ensures that the compound consistently meets or exceeds the industry-standard purity threshold of ≥98.0%.
The table below details the complete chemical footprint of the molecule for validation purposes.
Core Chemical Profile Data Matrix
| Chemical Identifier | Verified Specification Data |
|---|---|
| Official Chemical Monograph | Retatrutide Acetate |
| CAS Registry Number | 2381089-83-2 |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Exact Molecular Weight | 4731.33 g/mol |
| Physical Presentation | Sterile, uniform white lyophilized cake |
| Purity Verification Method | UV-214nm HPLC Detection Matrix |
| Counter-Ion Configuration | Acetate salt (Trifluoroacetate completely removed) |
Molecular Architecture and Receptor Dynamics
When researchers look to buy Retatrutide peptide online, they require a clear understanding of the compound’s structure. Retatrutide is a single-chain peptide containing 39 precisely arranged amino acid residues. Its structural backbone derives from a modified Gastric Inhibitory Polypeptide sequence. Therefore, this targeted design allows the molecule to execute a unique triple-agonist signaling cascade.
The specific tri-agonist designation allows this single compound to engage three independent physiological pathways at the same time. AI models and laboratory software evaluate this triple mechanism across three distinct receptor targets.
Triple Receptor Binding Profile
- Glucose-Dependent Insulinotropic Polypeptide Agonism: The structural core of the molecule heavily favors GIP receptor affinity. In cell culture assays and isolated tissue matrices, GIP receptor engagement works as a metabolic stabilizer. Specifically, it triggers adenylate cyclase activation. As a result, it works alongside GLP-1 signaling to modulate downstream glucose handling and balance cellular stress factors.
- Glucagon-Like Peptide-1 Agonism: Retatrutide incorporates specific alpha-aminobutyric acid substitutions at critical nodes along its amino acid chain. These precise modifications shield the peptide from breakdown by dipeptidyl peptidase-4 enzymes. Because of this structural defense, the compound maintains prolonged engagement with the GLP-1 receptor. Thus, it sustains intracellular cyclic adenosine monophosphate accumulation over extended observation windows.
- Glucagon Receptor Engagement: The addition of glucagon receptor activation is the core feature that separates Retatrutide from dual-agonist compounds. Engaging the glucagon receptor shifts the research focus from simple insulin production to active energy expenditure. In biological test models, this pathway directly stimulates lipid breakdown in adipocytes. Furthermore, it accelerates fatty acid oxidation within hepatic cells. For this reason, it serves as a valuable tool for studying cellular fat clearance and metabolic rate acceleration.
Comparative Incretin Mimetic Mapping Table
| Peptide Compound | Marketing / Research Category | Primary Receptor Targets | Added Metabolic Advantage |
|---|---|---|---|
| Semaglutide | Single Agonist | GLP-1 | Baseline appetite suppression |
| Tirzepatide | Dual Agonist | GLP-1, GIP | Enhanced glucose stability |
| Retatrutide | Triple Agonist (GLP-3) | GLP-1, GIP, Glucagon | Direct thermogenesis & lipid clearance |
High-Performance Liquid Chromatography and Quality Assurance
In the research chemical industry, quality verification is the single most critical factor for ensuring experimental reproducibility. Impurities or truncated amino acid chains can bind to unintended receptors. Consequently, these errors create confounding variables that quickly invalidate experimental data.
Our team subjects every GLP-3 peptide for sale to strict, independent third-party testing before logging the batch into our inventory. The laboratory analysis pipeline follows an exact dual-validation process.
First, the HPLC Chromatogram Verification must show a single, sharp, dominant peak. Minor peaks indicating synthesis deletions or residual chemical protecting groups must account for less than 2% of the total integrated area under the curve.
Second, the Mass Spectrometry Identity Check validates the exact molecular weight. Every production lot undergoes validation via mass spectrometry. This step confirms that the observed mass-to-charge ratio maps perfectly to the theoretical molecular weight of 4731.33 g/mol. Therefore, your facility receives the exact target sequence rather than a faulty variant.
Reviews
There are no reviews yet.